Results 201 to 210 of about 1,063,418 (267)

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

open access: yesMolecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla   +4 more
wiley   +1 more source

Low-Dose H<sub>2</sub>O<sub>2</sub> Priming Improves Performance Under Simulated Marine Heatwave Conditions in a Coastal Bivalve. [PDF]

open access: yesGlob Chall
Mascitelli C   +14 more
europepmc   +1 more source

Global Bias-Aware Synthesis of Meta-Analyses Reveals Agroforestry's Potential for Improving Soil Health. [PDF]

open access: yesGlob Chang Biol
Camille Manon R   +6 more
europepmc   +1 more source

Structures of protein folding intermediates on the ribosome. [PDF]

open access: yesNat Struct Mol Biol
Chan SHS   +8 more
europepmc   +1 more source

Medicinal Amazonian Oleoresins: An Eco-Friendly Chemical Fingerprinting Method. [PDF]

open access: yesPlants (Basel)
Ribeiro R   +4 more
europepmc   +1 more source

Cultivar to chemotype: characterizing complex botanicals with mass spectrometry metabolomics.

open access: yesNat Prod Rep
Kellogg JJ   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy